RZLT

RZLT

USD

Rezolute Inc. Common Stock (NV)

$8.900-0.020 (-0.224%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$8.920

Máximo

$9.000

Mínimo

$8.820

Volumen

1.64M

Fundamentos de la Empresa

Capitalización de Mercado

808.4M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

1.24M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $2.215Actual $8.900Máximo $10.04

Noticias Relacionadas

Analyst Upgrades

Citizens Maintains Market Outperform on Rezolute, Raises Price Target to $17

Citizens analyst Jason N. Butler maintains Rezolute with a Market Outperform and raises the price target from $9 to $17.

Ver más
Citizens Maintains Market Outperform on Rezolute, Raises Price Target to $17
GlobeNewswire

Rezolute to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ:RZLT) ("Rezolute" or the "Company"), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today

Ver más
Rezolute to Participate in Upcoming Investor Conferences
GlobeNewswire

Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ: RZLT), ("Rezolute" or the "Company"), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today

Ver más
Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.